13 patents
Utility
Targeted Immunotolerance
10 Feb 22
Methods and compounds for conferring site-specific or local immune privilege.
Joanne L. Viney, Nathan Higginson-Scott, Micah Benson, Alan Crane, Kevin Lewis Otipoby
Filed: 18 Sep 19
Utility
Targeted Immunotolerance
6 Jan 22
Methods and compounds for conferring site-specific or local immune privilege.
Joanne L. Viney, Nathan Higginson-Scott, Micah Benson, Alan Crane
Filed: 10 Feb 21
Utility
Targeted Immunotolerance
9 Sep 21
Methods and compounds for conferring site-specific or local immune privilege.
Nathan HIGGINSON-SCOTT, Joanne L. VINEY, Jyothsna VISWESWARAIAH, Erik Robert SAMPSON, Kevin Lewis OTIPOBY
Filed: 20 Nov 18
Utility
Tissue Targeted Immunotolerance with a CD39 Effector
2 Sep 21
Methods and compounds for conferring site-specific or local immune privilege, such as to the skin.
Daniel Rios, Purvi Mande, Joanne L. Viney, Nathan Higginson-Scott, Kevin Lewis Otipoby, Susmita Borthakur, Salvatore Alioto, Lindsay J. Edwards
Filed: 18 Feb 21
Utility
IL-2 muteins and uses thereof
17 Aug 21
The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby
Filed: 25 Nov 19
Utility
IL-2 muteins and uses thereof
17 Aug 21
The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby
Filed: 25 Nov 19
Utility
Targeted Immunotolerance with a PD-1 Agonist
8 Jul 21
Methods and polypeptides for conferring site-specific or local immune privilege.
Nathan Higginson-Scott, Joanne L. Viney, Kevin Lewis Otipoby, Salvatore Alioto, Lindsay J. Edwards, Jacob Glanville, David Maurer, Sarah Ives, Sawsan Youssef, Devanshi Shanghavi, Lauren Schwimmer
Filed: 19 Aug 20
Utility
Targeted Immunotolerance
1 Apr 21
Methods and compounds for conferring site-specific or local immune privilege.
Joanne L. Viney, Nathan Higginson-Scott
Filed: 24 Apr 20
Utility
Targeted immunotolerance
30 Mar 21
Methods and compounds for conferring site-specific or local immune privilege.
Joanne L. Viney, Nathan Higginson-Scott, Micah Benson, Alan Crane
Filed: 15 Mar 18
Utility
IL-2 muteins and uses thereof
16 Mar 21
The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby
Filed: 28 Nov 18
Utility
MAdCAM TARGETED IMMUNOTOLERANCE
16 Dec 20
Methods and compounds for conferring site-specific or local immune privilege, such as targeting to a cell expressing MAdCAM.
Nathan Higginson-Scott, Joanne L. Viney, Kevin Lewis Otipoby, Jyothsna Visweswaraiah, Salvatore Alioto, Lindsay J. Edwards, Erik Sampson, Jacob Glanville, David Maurer, Sarah Ives, Christina Pettus, Lauren Schwimmer
Filed: 19 May 20
Utility
IL-2 Muteins and Uses Thereof
14 Oct 20
The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby
Filed: 24 Nov 19
Utility
IL-2 Muteins and Uses Thereof
14 Oct 20
The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby
Filed: 24 Nov 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first